Virtus ETF Advisers LLC Karyopharm Therapeutics Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $231,136 - $381,974	-44,364 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $18,084 - $43,200	-4,064 Reduced 8.39%	44,364 $258,000
Q2 2021 Aug 10, 2021	BUY	$8.11 - $11.11 $66,834 - $91,557	8,241 Added 20.51%	48,428 $500,000
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $10,805 - $19,405	1,097 Added 2.81%	40,187 $423,000
Q4 2020 Feb 12, 2021	BUY	$14.15 - $17.19 $57,901 - $70,341	4,092 Added 11.69%	39,090 $605,000
Q3 2020 Nov 13, 2020	BUY	$14.14 - $19.71 $41,684 - $58,105	2,948 Added 9.2%	34,998 $511,000
Q2 2020 Aug 05, 2020	SELL	$16.6 - $25.25 $51,194 - $77,871	-3,084 Reduced 8.78%	32,050 $607,000
Q1 2020 May 14, 2020	SELL	$14.38 - $27.72 $42,622 - $82,162	-2,964 Reduced 7.78%	35,134 $675,000
Q4 2019 Feb 13, 2020	SELL	$9.23 - $19.67 $56,746 - $120,931	-6,148 Reduced 13.9%	38,098 $730,000
Q3 2019 Nov 12, 2019	SELL	$5.66 - $11.85 $13,951 - $29,210	-2,465 Reduced 5.28%	44,246 $426,000
Q2 2019 Aug 13, 2019	BUY	$4.32 - $6.43 $83,462 - $124,227	19,320 Added 70.53%	46,711 $280,000
Q1 2019 May 14, 2019	SELL	$4.12 - $10.25 $13,740 - $34,183	-3,335 Reduced 10.85%	27,391 $160,000
Q4 2018 Feb 05, 2019	BUY	$8.2 - $16.95 $36,801 - $76,071	4,488 Added 17.1%	30,726 $288,000
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $319,278 - $397,082	-18,748 Reduced 41.68%	26,238 $447,000
Q2 2018 Aug 10, 2018	SELL	$12.0 - $19.88 $436,068 - $722,419	-36,339 Reduced 44.68%	44,986 $764,000
Q1 2018 May 14, 2018	BUY	$9.92 - $17.25 $439,971 - $765,072	44,352 Added 119.96%	81,325 $1.09 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $10,952 - $14,352	1,197 Added 3.35%	36,973 $355,000
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $26,666 - $36,515	3,272 Added 10.07%	35,776 $393,000
Q2 2017 Aug 14, 2017	BUY	N/A	32,504	32,504 $294,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account